| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.25 | 1e-13 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-12 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-12 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-11 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-11 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.27 | 4e-11 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.25 | 8e-11 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-10 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-09 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-09 |